Vilnius, Lithuania

Giedrius Vilkaitis

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Achievements of Giedrius Vilkaitis

Introduction: Giedrius Vilkaitis is a notable inventor based in Vilnius, Lithuania. He has made significant contributions to the field of molecular biology, particularly in the analysis and modification of RNA. With a focus on improving RNA strands, his work has potential implications for various biotechnological applications.

Latest Patents: Giedrius Vilkaitis holds a patent titled "Analysis of single-stranded RNA." This innovative patent provides a method for modifying single-stranded RNA (ssRNA) at the 3' end. The method involves contacting the strand with a ssRNA 2′-O-methyltransferase in the presence of a co-factor. This process allows the transfer of part of the co-factor onto the 3′ end of the ssRNA, resulting in a modified ssRNA that bears a 2′-OH group at the 3′ terminal nucleotide. The transferred part of the co-factor includes either a reporter group or a functional group, which can enhance the usability of the modified RNA.

Career Highlights: Vilkaitis is affiliated with Vilnius University, where he has been able to leverage academic resources to pursue his research interests. His involvement in the scientific community has led to advancements in RNA research, strengthening his reputation as an innovative thinker in the field.

Collaborations: Throughout his career, Giedrius Vilkaitis has collaborated with notable colleagues such as Saulius Klimasauskas and Milda Mickute. These partnerships have enriched his research endeavors, enabling a productive exchange of ideas and expertise, thus driving innovation in RNA analysis.

Conclusion: Giedrius Vilkaitis embodies the spirit of innovation with his work on single-stranded RNA modifications. His patent reflects his commitment to advancing scientific understanding in molecular biology. As he continues his work at Vilnius University, the implications of his research may pave the way for future breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…